Dr Agarwal’s Healthcare IPO (Dr Agarwal’s Health Care Limited IPO)
Dr Agarwal’s Healthcare IPO open for bidding on 29th January 2025 and ends on 31st January 2025.
Dr. Agarwal’s Health Care Limited, established in 2010, is a leading player in India’s eye care specialty sector. The company operates a vast network of eye hospitals and clinics across India and internationally, delivering advanced ophthalmological services. With a focus on cutting-edge technology and highly skilled specialists, the organization provides services such as cataract surgery, LASIK, and retinal care.
The company’s strong brand presence stems from its patient-centric approach, offering tailored treatment plans and innovative care solutions. With a diversified portfolio of advanced eye care services, Dr. Agarwal’s Health Care is a trusted name in healthcare.
For more details refer to Dr Agarwal’s Healthcare IPO RHP and Dr Agarwal’s Healthcare IPO Pulse Score
Dr Agarwal’s Healthcare IPO Details
| IPO Date | 29th January 2025 to 31st January 2025 |
| Listing Date | 4th February 2025 |
| Face Value | ₹1 per share |
| Price Band | ₹382 to ₹402 per share |
| Lot Size | 35 Shares |
| Total Issue Size | 7,53,04,970 shares (aggregating up to ₹3,027.26 Cr) |
| Fresh Issue | 74,62,686 shares (aggregating up to ₹300.00 Cr) |
| Offer for Sale | 6,78,42,284 shares of ₹1 (aggregating up to ₹2,727.26 Cr) |
| Issue Type | Book Built Issue IPO |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor | 2,17,78,798(28.9%) |
| QIB | 1,45,19,200(19.3%) |
| NII | 1,08,89,400(14.5%) |
| bNII | 72,59,600(9.6%) |
| sNII | 36,29,800(4.8%) |
| Retail | 2,54,08,599(33.7%) |
| Employees | 15,79,399(2.1%) |
| Shareholders | 11,29,574(1.5%) |
| Total | 7,53,04,970(100%) |
Dr Agarwal’s Healthcare IPO Timeline
| IPO Open | 29th January 2025 |
| IPO Close | 31st January 2025 |
| Basis Of Allotment | 1st February 2025 |
| Initiation of Refunds | 3rd February 2025 |
| Credit of Shares to Demat | 3rd February 2025 |
| Listing Date | 4th February 2025 |
Fundamentals
Data as of 30th September 2024
| Market Cap | ₹12,698.37 Cr | P/E Ratio- Pre IPO | 130.44 |
| RoNW* | 1.90% | P/E Ratio- Post IPO | 160.48 |
| RoCE* | 8.30% | P/B Ratio | 7.96 |
| Debt to Equity | 0.55 | PAT Margin | 4.72% |
Note: P/E Ratio -Pre IPO is calculated based on Pre-issue Shareholding and FY Earnings of March 2024. P/E Ratio- Post IPO is calculated based on post-issue shareholding and annualized FY earnings for September 2024. RoCE and RoNW are for six-month period ended September 30, 2024
Dr Agarwal’s Healthcare IPO Objectives
The company proposes to utilize the Net Proceeds towards the funding of the following objects:
- Repayment/prepayment, in part or full, of certain borrowings; and
- General corporate purposes and unidentified inorganic acquisition.
- Dr Agarwal’s Healthcare IPO Subscription Status
- Dr Agarwal’s Healthcare IPO Allotment Status
- Dr Agarwal’s Healthcare IPO Reviews
Leave a Reply